Loading cancer entity…
Loading cancer entity…
Variants & evidence
2 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| LZTR1 LOSS-OF-FUNCTION1 | |||||||
| (predisposing) | Predisposing | B | Supports Pathogenic | 5 | submitted | EID7058Germline loss-of-function mutations in LZTR1 is a SMARCB1-independent predisposing factor that leads to Schwannomatosis, a late-onset tumor predisposition disorder. PMID 24362817 · Piotrowski et al., 2014 · Open in CIViC | civic |
| HTRA1 Fusion1 | |||||||
| (diagnostic) | Diagnostic | C | Supports Positive | 2 | submitted | EID10311SH3PXD2A-HTRA1 gene fusion was found in Schwannomatosis(SWNTS)-schwannomas (SWNs) PMID 33112994 · Mansouri et al., 2021 · Open in CIViC | civic |
Data updated 1 hour agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.